Publications

Veerle Geurts

2024

  1. Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
    JAMA Oncology
    V. C. M. Geurts, S. Balduzzi, T. G. Steenbruggen, S. C. Linn, S. Siesling, S. S. Badve, A. Demichele, M. Ignatiadis, R. A. Leon-Ferre, M. P. Goetz, A. C. Wolff, N. Klar, S. Michiels, S. Loi, S. Adams, H. M. Horlings, G. S. Sonke, R. Salgado, M. Kok, 2024
    doi
    Abstract

2023

  1. 474P ctDNA-based copy number dynamics during anti-PD1 treatment in patients with metastatic triple-negative breast cancer
    Annals of Oncology
    A. Lin, O. Isaeva, D. Vessies, T. Deger, L. Voorwerk, V. Geurts, H. Horlings, J. Martens, L. Wessels, D. Van Den Broek, M. Kok, 2023, 34
    doi
    Abstract
  2. Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial
    The Breast
    V. Geurts, L. Voorwerk, S. Balduzzi, R. Salgado, K. Van De Vijver, M. Van Dongen, I. Kemper, I. Mandjes, M. Heuver, W. Sparreboom, J. Haanen, G. Sonke, H. Horlings, M. Kok, 2023, 70
    doi paper (open access)
    Abstract
  3. Abstract P3-06-01: Unleashing NK- and CD8 T cells by combining monalizumab (anti-NKG2A) and trastuzumab for metastatic HER2+ breast cancer: first results MIMOSA trial
    Cancer Research
    V. Geurts, L. Voorwerk, K. Sikorska, R. Salgado, K. Van De Vijver, M. Van Dongen, I. Kemper, I. A. Mandjes, M. Heuver-Mes, J. Haanen, G. S. Sonke, H. Horlings, M. Kok, 2023, 83;(5_Supplement):P3-06-01-P3-06-01
    doi
    Abstract